Free Trial

Digital Health Acquisition (DHAC) Competitors

Digital Health Acquisition logo
$0.67 +0.04 (+6.89%)
As of 10/8/2025

DHAC vs. DCGO, SERA, CORBF, QIPT, BNR, EUDA, PIII, ATPC, BDSX, and BMGL

Should you be buying Digital Health Acquisition stock or one of its competitors? The main competitors of Digital Health Acquisition include DocGo (DCGO), Sera Prognostics (SERA), Global Cord Blood (CORBF), Quipt Home Medical (QIPT), Burning Rock Biotech (BNR), EUDA Health (EUDA), P3 Health Partners (PIII), Agape ATP (ATPC), Biodesix (BDSX), and Basel Medical Group (BMGL). These companies are all part of the "healthcare" industry.

Digital Health Acquisition vs. Its Competitors

DocGo (NASDAQ:DCGO) and Digital Health Acquisition (NASDAQ:DHAC) are both small-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their dividends, profitability, media sentiment, earnings, institutional ownership, risk, analyst recommendations and valuation.

DocGo currently has a consensus target price of $3.24, suggesting a potential upside of 181.52%. Given DocGo's stronger consensus rating and higher possible upside, equities research analysts clearly believe DocGo is more favorable than Digital Health Acquisition.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DocGo
2 Sell rating(s)
3 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.00
Digital Health Acquisition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

DocGo has a beta of 0.95, meaning that its stock price is 5% less volatile than the S&P 500. Comparatively, Digital Health Acquisition has a beta of 0.23, meaning that its stock price is 77% less volatile than the S&P 500.

In the previous week, DocGo had 5 more articles in the media than Digital Health Acquisition. MarketBeat recorded 5 mentions for DocGo and 0 mentions for Digital Health Acquisition. DocGo's average media sentiment score of 0.37 beat Digital Health Acquisition's score of 0.00 indicating that DocGo is being referred to more favorably in the media.

Company Overall Sentiment
DocGo Neutral
Digital Health Acquisition Neutral

56.4% of DocGo shares are held by institutional investors. Comparatively, 1.0% of Digital Health Acquisition shares are held by institutional investors. 3.8% of DocGo shares are held by insiders. Comparatively, 6.6% of Digital Health Acquisition shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Digital Health Acquisition has a net margin of 0.00% compared to DocGo's net margin of -4.20%. Digital Health Acquisition's return on equity of 0.00% beat DocGo's return on equity.

Company Net Margins Return on Equity Return on Assets
DocGo-4.20% -3.26% -2.24%
Digital Health Acquisition N/A N/A N/A

DocGo has higher revenue and earnings than Digital Health Acquisition.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DocGo$616.55M0.18$19.99M-$0.19-6.05
Digital Health AcquisitionN/AN/AN/AN/AN/A

Summary

DocGo beats Digital Health Acquisition on 8 of the 12 factors compared between the two stocks.

Get Digital Health Acquisition News Delivered to You Automatically

Sign up to receive the latest news and ratings for DHAC and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding DHAC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DHAC vs. The Competition

MetricDigital Health AcquisitionHolding Offices IndustryServices SectorNASDAQ Exchange
Market Cap$2.42M$239.43M$1.62B$10.23B
Dividend YieldN/A3.13%6.51%4.69%
P/E RatioN/A0.175.0626.57
Price / SalesN/A456.8218.15179.01
Price / CashN/A123.70176.9862.20
Price / BookN/A7.363.556.53
Net IncomeN/A-$12.18M-$22.18M$275.87M
7 Day Performance8.34%1.44%-6.85%-1.40%
1 Month Performance0.31%16.35%-4.80%5.16%
1 Year Performance-44.13%323.96%-13.93%31.51%

Digital Health Acquisition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DHAC
Digital Health Acquisition
N/A$0.67
+6.9%
N/A-45.9%$2.42MN/A0.002,021
DCGO
DocGo
1.878 of 5 stars
$1.27
-0.8%
$3.24
+154.9%
-62.5%$124.22M$435.97M-6.684,407News Coverage
Analyst Downgrade
SERA
Sera Prognostics
1.2306 of 5 stars
$3.25
+3.8%
N/A-50.2%$122.44M$108K-3.82120Analyst Forecast
CORBF
Global Cord Blood
N/A$1.00
flat
N/AN/A$121.55M$196.12M0.001,200
QIPT
Quipt Home Medical
2.8521 of 5 stars
$2.61
-0.8%
$3.15
+20.7%
-6.7%$113.39M$238.38M-10.871,200Analyst Forecast
BNR
Burning Rock Biotech
0.822 of 5 stars
$9.14
+1.4%
N/A+152.4%$98.35M$70.67M-4.811,390News Coverage
Analyst Forecast
EUDA
EUDA Health
1.0847 of 5 stars
$2.23
+8.3%
N/A-27.5%$82.86M$4.01M0.002
PIII
P3 Health Partners
2.8127 of 5 stars
$8.65
+1.8%
$16.25
+87.9%
-43.7%$62.17M$1.46B-0.19500News Coverage
Analyst Forecast
ATPC
Agape ATP
0.6487 of 5 stars
$1.17
-0.4%
N/A-32.0%$58.26M$1.45M-2.8440Analyst Forecast
BDSX
Biodesix
3.2857 of 5 stars
$7.74
+0.5%
$32.50
+319.9%
-76.1%$56.73M$71.32M-1.33220Analyst Forecast
BMGL
Basel Medical Group
N/A$1.61
-1.8%
N/AN/A$29.71M$10.00M0.0036Positive News
Analyst Forecast

Related Companies and Tools


This page (NASDAQ:DHAC) was last updated on 10/10/2025 by MarketBeat.com Staff
From Our Partners